MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies and could be game-changing for patients suffering from Gram-negative, MBL-resistant infections Meropenem resistance in India is as high as 62-87%, with up to 50% linked to MBL prevalence, according to ICMR
Rusan Pharma Ltd., is a global leader in pharmaceutical innovation, proudly announces that its Chairman, Dr. Navin Saxena, has been honoured with two of Russia’s most distinguished accolades, ‘The Order of Friendship’ by the Russian Federation & the ‘Memorial Medal’ from Moscow’s People’s Friendship University. These honours recognise
Syngene International Limited today announced that Jonathan Hunt has stepped down from his role as MD & CEO as well as from the Board of Directors to pursue other opportunities in due course. Consequent to this, the Board has appointed Peter Bains as the CEO
Latest approvals from Indonesia, Southeast Asia’s largest pharma market, to help strengthen company’s regional and global aspirations Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading Indian exporter of generic drugs, has received marketing authorization from Indonesia, Southeast Asia’s largest pharmaceutical market, for its Enoxaparin in
Revenue grows by 15%; Net Profit up 36% year-on-year Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, Contract Research and Development Organization (CRDMO) today announced its financial results for the third quarter and nine months ended December 31, 2024. Financial Performance: Particulars (₹ crores) Q3FY25 Q3FY24 YoY% 9MFY25 9MFY24 YoY% Revenue
Cotecna Life Sciences India Private Limited, formerly Geo-Chem Pharma, is proud to announce the inauguration of its new, state-of-the-art laboratory in Mumbai. This development represents a significant step in supporting the rapid growth of India’s pharmaceutical industry and demonstrates Cotecna’s dedication to fostering innovation, quality,
Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received final approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine Dimesylate Capsules in strengths
Mankind Pharma, a renowned global pharmaceutical company, has set up a comprehensive healthcare camp at the Mahakumbh 2025 in Prayagraj, Uttar Pradesh, India, offering essential medical services and support to thousands of pilgrims. The initiative, which commenced on 13th January and will continue through to
Granules India Ltd., a vertically integrated pharmaceutical company, today announced its financial results for the quarter ended December 31, 2024. Financial Summary (All numbers in INR Mn., except Margins) QUARTERLY CONSOLIDATED FINANCIALS Q3FY25 Q2FY25 Growth (QoQ) Q3FY24 Growth (YoY) Revenue from Operations 11,377 9,666 18% 11,556 -2% EBITDA 2,303 2,033 13% 2,505 -8% EBITDA % 20% 21% 22% PAT 1,176 972 21% 1,257 -6% PAT % 10% 10% 11% Financial and Business Summary for Q3FY25 The Company voluntarily paused
Dr Mahesh D M, Consultant Endocrinologist, Aster CMI Hospital Ozempic is currently one of the most popular drugs on the market, with many Hollywood as well as Bollywood celebs allegedly using it to lose weight. Recently on Christmas, Tesla and SpaceX CEO Elon Musk took to
